Germline variants of base excision repair genes and breast cancer: A polymorphism in DNA polymerase gamma modifies gene expression and breast cancer risk. Issue 1 (26th June 2012)

• Record Type: Journal Article
• Authors: Popanda, Odilia; Seibold, Petra; Nikolov, Ivaylo; Oakes, Christopher C.; Burwinkel, Barbara; Hausmann, Sebastian; Flesch‐Janys, Dieter; Plass, Christoph; Chang‐Claude, Jenny; Schmezer, Peter
• Is Part Of: International journal of cancer. Volume 132:Issue 1(2013:Jan. 01)
• Page Start: 55
• Page End: 62
• Publication Date: 2012-06-26
• Subjects: Cancer -- Periodicals; Cancer -- Prevention -- Periodicals; 616.994
• DOI: 10.1002/ijc.27665
• Languages: English
• ISSNs: 0020-7136

Abstract

<abstract abstract-type="main" xml:lang="en"> <title>Abstract</title> <p>Base excision repair (BER) removes DNA damage induced by endogenous reactive oxygen species or ionizing radiation, important breast cancer risk factors. Genetic variation associated with impaired BER might thus increase breast cancer risk. Therefore, we assessed risk associations of 123 common single nucleotide polymorphisms (SNPs) in 19 BER genes in 1, 639 postmenopausal breast cancer cases and 1, 967 controls from the German population‐based case‐control study MARIE. SNPs were tagging SNPs representing genetic variation across the gene together with potentially functional SNPs. Risk associations were assessed using conditional logistic regression, adjusted for potential breast cancer risk factors. Significant associations between polymorphisms and breast cancer risk were found for one SNP in <italic>PARP2</italic> and three SNPs in the mitochondrial DNA polymerase gamma, <italic>POLG</italic>. A SNP in the promoter region of <italic>POLG</italic> (rs2856268, A>G) showed a protective effect for homozygous GG carriers (odds ratio 0.81, 95% confidence intervals 0.65–1.00). Joint analysis of an enlarged sample set and haplotype analysis supported the results for <italic>POLG</italic>. Quantification of <italic>POLG</italic> mRNA expression in lymphocytes of 148 breast cancer patients revealed higher mRNA levels for rs2856268 GG carriers (<italic>p</italic> value = 0.038). A luciferase promoter assay showed significant differences between constructs harboring the respective alleles. Taken together, our results suggest that genetic variation in the <italic>POLG</italic> promoter region affects DNA polymerase gamma levels in mitochondria. This could contribute to the reported increase in mitochondrial mutation frequency resulting in dysfunction and altered breast cancer risk. Risk effects and the functional impact of the <italic>POLG</italic> promoter variant require further confirmation.</p> </abstract>